港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫美概念股

951.843

+3.3210.35%

漲家數：5

跌家數：4

平家數：4

市盈率：- -

高：962.122

開：950.038

低：933.927

收：948.522

成交量：5,714.21萬

成交額：5.75億

市值：1,569.12億

流通市值：1,171.29億

資料載入中...

總覽新聞資訊

《業績》復星醫藥(02196.HK)中期純利17.21億人民幣增1.1% 不派息

阿斯达克财经

中國復星醫藥上半年淨利按年增1.2%，創新藥品與境外業務穩健增長

昊海生物科技(06826.HK)8月25日耗資19.62萬港元回購1.2萬股

【券商聚焦】中信建投：醫療器械板塊估值正在重構

昊海生物科技(06826)8月24日斥資393.9萬港元回購24.96萬股

瑞麗醫美(02135)股價顯著下跌14.286%，現價港幣$0.102

阿斯达克财经

醫美板塊整體承壓時代天使（06699）跌2.53%、四環醫藥（00460）跌2.29%

《業績》昊海生物科技(06826.HK)中期純利1.13億人民幣跌46.6% 派息25分

阿斯达克财经

昊海生物科技(06826)將於10月16日派發中期股息每股0.25元

昊海生物科技(06826.HK)：田敏獲委任為授權代表

昊海生物科技(06826.HK)公布中期業績歸母淨利潤約1.13億元按年減少46.64%

港股午評|恒生指數早盤漲0.72% 鋰礦股漲幅居前

復星醫藥(02196.HK)治療HTG小核酸創新藥FXR0906完成中國I期臨床首例參與者給藥

阿斯达克财经

港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%

三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠

三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元按年減少15.58%

三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬

阿斯达克财经

港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段

復星醫藥(02196)股價上升8.483%，現價港幣$18.16

阿斯达克财经

港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%

老虎资讯综合

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/BK1593/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"醫美概念股","latestPrice":951.843,"timestamp":1787645292709,"preClose":948.5223,"halted":0,"volume":57142098,"delay":0,"changeRate":0.003501,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":3.32074,"latestTime":"08-25 16:00:00","open":950.0384,"high":962.1216,"low":933.9272,"amount":574625275,"amplitude":0.029725,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"pbRate":1.204102,"peRate":11.218186,"turnoverRate":0.002762,"increases":5,"decrements":4,"flats":4,"marketCap":156912127448,"floatMarketCap":117129149144},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":962.1216,"amplitude":0.029725,"preClose":948.5223,"low":933.9272,"pbRate":"1.204102","latestPrice":951.843,"volume":57142098,"delay":0,"open":950.0384,"prevYearClose":1094.978,"prevWeekClose":957.756,"prevMonthClose":920.614,"prevQuarterClose":846.145,"fiveDayClose":944.095,"twentyDayClose":933.838,"sixtyDayClose":911.147,"secType":"PLATE","market":"HK","turnoverRate":0.002762,"peRate":11.218186,"marketCap":156912127448,"floatMarketCap":117129149144,"timestamp":1787645292709,"nameCN":"醫美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":5,"down":4,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662759931","title":"《業績》復星醫藥(02196.HK)中期純利17.21億人民幣增1.1%  不派息","url":"https://stock-news.laohu8.com/highlight/detail?id=2662759931","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662759931?lang=zh_tw&edition=fundamental","pubTime":"2026-08-26 01:24","pubTimestamp":1787678640,"startTime":"0","endTime":"0","summary":"复星医药(02196.HK) 公布6月止六个月中期业绩，收入203.77亿人民币(下同)，按年增加4.9%；毛利100.88亿元，上升8.5%。录得纯利17.21亿元，增长1.1%，每股盈利65分。不派息。(d)(港股报价延迟最少十五分钟。沽空资料截至 2026-08-25 16:25。)过往派息公布日期派息事项派息内容2026/04/28第一季业绩无派息2026/03/25末期业绩股息：人民币 0.3900 (约相等于 0.45 港元)2025/10/28第三季业绩无派息2025/08/26中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180321105506149_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180321105506149_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540737/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540737/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0187","BK1191","BK0060","BK0183","BK0196","CNHmain","02196","BK0012","BK0175","BK0028","BK0096","UCmain","MCNHmain","BK1515","600196","MUCmain","BK0239","BK0188","CYB","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662733637","title":"中國復星醫藥上半年淨利按年增1.2%，創新藥品與境外業務穩健增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2662733637","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662733637?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 18:02","pubTimestamp":1787652146,"startTime":"0","endTime":"0","summary":"中国复星医药上半年净利同比增1.2%，创新药品与境外业务稳健增长路透北京8月25日-中国“复星系”医药及疫苗巨头--复星医药600196.SS2196.HK周二公布，上半年净利同比增1.2%，营收同比增4.8%，主要得益于创新药品与境外业务稳健增长。该公司在上交所刊登的财报显示，上半年实现净利17.2亿元人民币，营收204.4亿元；同期扣除非经常性损益的净利11.4亿元，同比增19.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nL4T44M0KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK0028","BK0175","BK0187","BK0239","BK0060","BK0196","BK1191","BK0183","BK0096","BK1593","02196","600196","BK0012","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662780752","title":"昊海生物科技(06826.HK)8月25日耗資19.62萬港元回購1.2萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662780752","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662780752?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 17:27","pubTimestamp":1787650027,"startTime":"0","endTime":"0","summary":"格隆汇8月25日丨昊海生物科技(06826.HK)发布公告，2026年8月25日耗资19.62万港元回购1.2万股，回购价格每股16.3-16.49港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260825/32346519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","BK1593","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662705207","title":"【券商聚焦】中信建投：醫療器械板塊估值正在重構","url":"https://stock-news.laohu8.com/highlight/detail?id=2662705207","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662705207?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 09:32","pubTimestamp":1787621521,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，建议2026年加配医疗器械板块，短期来看，建议把握2026年业绩改善个股的业绩和估值修复机会，高值耗材和IVD板块的集采或降价影响将于下半年逐步出清，多家细分赛道龙头将于2026年迎来加速增长，同时建议关注手术机器人、脑机接口等新科技方向，相关技术突破和商业化落地有望持续催化板块热度。长期来看，医疗器械板块投资机会来自创新、出海和并购整合，板块的创新和国际化能力得到认可，估值正在重构。风险提示：行业政策风险、研发不及预期风险、审批不及预期风险、宏观环境波动风险、中东地缘政治风险。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02235","PTH","BK1189","BK1161","BK1571","BK0276","KCE","GDOC","BK1589","09996","MDEV","BK1584","BK1593","LGHT","01066","BK1247","BK1591","00853","RSPH","BK1615","LU0287142896.SGD","02252","02190","HK0000165453.HKD","LNGR","HART","IEIH","BK1600","AGNG","BK1617","01302","LU0173614495.USD","00241","BK1515","BK1610","MEDX","601066","BK1502","BK1585","BK1574","BK1501","BK1222","159883","BK1100","BK1583","BK1142","06826","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222503","title":"昊海生物科技(06826)8月24日斥資393.9萬港元回購24.96萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222503","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222503?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 17:25","pubTimestamp":1787563513,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2026年8月24日斥资393.9万港元回购24.96万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661223350","title":"瑞麗醫美(02135)股價顯著下跌14.286%，現價港幣$0.102","url":"https://stock-news.laohu8.com/highlight/detail?id=2661223350","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661223350?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 13:20","pubTimestamp":1787548800,"startTime":"0","endTime":"0","summary":"[下跌股]瑞丽医美(02135) 股价在下午01:19比前收市价显著下跌14.286%，现股价为港币$0.102。至目前为止，今日最高价为$0.102，而最低价为$0.102。总成交量为1万股，总成交金额为港币$1020。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608244288/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2608244288/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1209","BK1593","02135"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661473242","title":"醫美板塊整體承壓 時代天使（06699）跌2.53%、四環醫藥（00460）跌2.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661473242","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661473242?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 10:33","pubTimestamp":1787538824,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医美板块整体承压，截至发稿，昊海生物科技 跌5.16%，时代天使跌2.53%，复星医药跌2.30%，四环医药跌2.29%，山东新华制药股份跌1.37%，现代牙科跌1.22%。华龙证券新近研究指，企业层面，国内医美企业持续突破海外监管认证，海外市场有望成为重要增长第二曲线，行业高质量发展态势明确。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NTQxOTRlZTU5ZGZkZjc4MmEzMTdjMTVhMTM1NjYxOTg3NzU=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1583","06826","BK1587","BK1593","00719","02196","BK1191","BK1161","03600","06699","00460","BK1100","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248296","title":"《業績》昊海生物科技(06826.HK)中期純利1.13億人民幣跌46.6%  派息25分","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248296","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661248296?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 19:34","pubTimestamp":1787484840,"startTime":"0","endTime":"0","summary":"昊海生物科技(06826.HK) 公布6月止六个月中期业绩，营业收入11.66亿人民币(下同)，按年下降9.8%。录得纯利1.13亿元，倒退46.6%，每股盈利49分。中期息25分，上年同期派40分。(d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/04/24第一季业绩无派息2026/03/20末期业绩股息：人民币 0.6000 (约相等于 0.688247 港元)2025/10/24第三季业绩无派息2025/08/22中期业绩股息：人民币 0.4000 (约相等于 0.438462 港元)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230627125933138_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540096/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1540096/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["MCNHmain","MUCmain","BK1593","UCmain","BK1161","CNHmain","CYB","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293799","title":"昊海生物科技(06826)將於10月16日派發中期股息每股0.25元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293799","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293799?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:30","pubTimestamp":1787319039,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司将于2026年10月16日派发中期股息每股0.25元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483686.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1593","BK4585","VIG","06826","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661429323","title":"昊海生物科技(06826.HK)：田敏獲委任為授權代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2661429323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661429323?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:25","pubTimestamp":1787318748,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293956","title":"昊海生物科技(06826.HK)公布中期業績 歸母淨利潤約1.13億元 按年減少46.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293956","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293956?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:15","pubTimestamp":1787318136,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661251291","title":"港股午評|恒生指數早盤漲0.72%     鋰礦股漲幅居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2661251291","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661251291?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 12:00","pubTimestamp":1787284830,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.72%，涨184点；恒生科技指数指数涨0.50%；港股早盘成交1360亿港元。天齐锂业涨8.8%；赣锋锂业涨超7%。恒生指数公司将于今日公布第二季度指数评估结果。思格新能或加入港股通标的，涨超10%。恒基地产涨超6%领涨蓝筹。中期股东应占盈利40.9亿港元，同比增加40.65%。中软国际绩后涨超7%，上半年股东应占溢利3.5亿元，同比增加11%。金嗓子盈警后跌超21%，预计上半年纯利同比跌四成，受销售费用增加拖累。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","09115","LU0359201885.HKD","LU0173614495.USD","07300","02837","LU0737861699.HKD","03115","LU1770034418.SGD","HK0000914686.HKD","BK1593","LU0359202008.SGD","300750","02788","MCHmain","BK1601","LU0572940350.SGD","83115","LU0345781412.USD","BK1113","BK1594","LU0630314457.HKD","02800","00012","01378","01772","03423","BK1129","LU1719994722.HKD","BK1207","002460","LU1152091754.HKD","00354","513600","LU1152091168.USD","BK1568","BK1526","LU0307460666.USD","03750","LU0572939691.SGD","HSTECH","LU1807302812.USD","LU1960683339.HKD","HK0000286598.CNH","BK1506","LU1023057109.AUD","LU1808992512.USD","LU0210526637.USD","07500","HK0000500386.USD","SG9999014674.SGD","BK1511","LU1224709979.USD","SG9999001093.SGD","LU1303224171.USD","07552","BK1559","BK1190","HK0000252160.HKD","HK0001040168.HKD","BK1610","BK1592","LU1993786604.SGD","06656","02600","LU2279858448.HKD","BK1589","SG9999003461.SGD","03417","LU0051755006.USD","06869","LU0287142896.SGD","LU0345780950.USD","LU1251922891.USD","06896","002466","03067","09696","HK0000914660.USD","03032","BK1518","LU0456827905.SGD","LU0469268626.HKD","BK1522","BK1175","03419","601869","BK1240","09088","82800","03088","LU0067412154.USD","09067","601600","LU0264606111.USD","BK1117","02706","BK1586","LU1166156734.SGD","LU1171460220.USD","HHImain","03033","SG9999006597.SGD","01866","BK1543","LU0359201612.USD","HK0001040143.USD","BK1500","BK1509","BK1170","BK1116","HLDCY","01530","BK1523","HSI","BK1161","BK1155","03037","LU0880133367.SGD","07200","00189","BK1149","HK0000165453.HKD","02833","LU0588546209.SGD","LU1008478684.HKD","BK1513","07226","BK1583","LU0702159699.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661225995","title":"復星醫藥(02196.HK)治療HTG小核酸創新藥FXR0906完成中國I期臨床首例參與者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2661225995","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661225995?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 10:35","pubTimestamp":1787279700,"startTime":"0","endTime":"0","summary":"复星医药宣布，用于治疗高甘油三酯血症的肝靶向siRNA小干扰核酸创新药FXR0906注射液，于近日在中国境内完成I期临床首例参与者给药。FXR0906由复星医药集团许可引进，并享有该药品于中国内地及港澳地区研究、开发、注册、生产及商业化的独占权利。截至目前，中国境内尚无用于治疗高甘油三酯血症的小干扰核酸药物获批上市。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190401142438853_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539809/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1539809/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0012","BK0060","BK1593","BK1191","BK0183","BK0239","BK0175","BK1574","BK0028","BK0187","600196","159992","BK0096","BK0196","06978","02196","BK0188","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661598772","title":"港股異動 | 三生製藥(01530)升逾7% 上半年經調整的經營性歸母淨利按年增長26.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661598772","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661598772?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 10:22","pubTimestamp":1787278953,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药(01530)涨超7%，截至发稿，涨6.85%，报17.63港元，成交额3.95亿港元。消息面上，三生制药发布2026年中期业绩。上半年公司实现营业收入45.3亿元，同比增长3.9%；归母净利润11.5亿元，同比减少15.58%；经调整的经营性归母净利润14.4亿元，同比增长26.5%。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。集团预期于可预见未来人民币汇率波动对经营并无重大不利影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483085.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK1583","01530","BK1593","HK0000165453.HKD","BK1161","BK4585","VXUS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233703","title":"三生製藥發布2026中期業績：創新驅動、合作共贏、行穩致遠","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233703","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233703?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 23:17","pubTimestamp":1787239022,"startTime":"0","endTime":"0","summary":"三生制药今日发布2026年中期业绩公告。今年上半年，公司实现营业收入45.3亿元，同比增长3.9%，归母净利润11.5亿元，经调整的经营性归母净利润14.4亿元，同比增长26.5%，研发费用6.8亿元，同比增长24.9%，公司财务资源194亿元，充裕的资金储备为研发投入和战略布局提供了坚实保障。上半年核心品种获全球23个国家上市许可，海外产品销售同比增长43%，来源于公司rhEPO、益赛普、rhTPO等品种在全球多个新兴经济体国家提升市场渗透率。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260820/32341912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01530","BK1593","HK0000165453.HKD","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238133","title":"三生製藥(01530.HK)發布中期業績，股東應占溢利11.47億元 按年減少15.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238133","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660238133?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 22:33","pubTimestamp":1787236399,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404750","title":"三生製藥(01530)出現大手買入46.15萬股，成交價$16.52，涉資762.398萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404750","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404750?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:59","pubTimestamp":1787212740,"startTime":"0","endTime":"0","summary":"[大手成交]三生制药(01530)在下午03:59出现大手买入，成交量为46.15万，成交价为港币$16.52，涉资762.398万。至目前为止，股价跌1.019%，今日最高价为$17.85，而最低价为$16.34，总成交量为5.623千万股，总成交金额港币$9.607亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2608206016/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01530","HK0000165453.HKD","BK1161","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660406619","title":"港股異動 | 四環醫藥(00460)升逾6% 上半年淨利預增不低於217.2% 公司醫美業務進入快速放量階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2660406619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660406619?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 14:18","pubTimestamp":1787206705,"startTime":"0","endTime":"0","summary":"消息面上，近期，四环医药业绩盈喜预告，集团预期于截至2026年6月30日止六个月取得收入不低于人民币11.4亿元，与去年同期大致持平；取得期内净利润不低于人民币2.1亿元，较去年同期增长不低于217.2%。该行认为，公司医美业务进入快速放量阶段，创新药及其他药品、仿制药业务盈利有望改善，公司经营拐点已至。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK1515","KCAI","BK1191","BK4585","BK4588","BK1593","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660477052","title":"復星醫藥(02196)股價上升8.483%，現價港幣$18.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2660477052","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660477052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:33","pubTimestamp":1787193180,"startTime":"0","endTime":"0","summary":"[上升股]复星医药(02196) 股价在上午10:33比前收市价上升8.483%，现股价为港币$18.16。至目前为止，今日最高价为$18.16，而最低价为$17.42。总成交量为597.604万股，总成交金额为港币$1.069亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608202496/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0012","BK0060","600196","BK0239","BK0028","BK0187","BK0196","BK0183","BK1191","BK1515","BK1593","BK0188","BK0175","02196","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162366260","title":"港股創新藥概念股集體走強，中國生物製藥升逾20%，石藥集團升逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162366260","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162366260?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 09:59","pubTimestamp":1787191169,"startTime":"0","endTime":"0","summary":"8月20日，港股创新药概念股集体走强，$中国生物制药(01177)$涨超20%，$石药集团(01093)$涨超16%，$晶泰控股(02228)$、$金斯瑞生物科技(01548)$涨超12%，$乐普生物(02157)$、$康方生物(09926)$涨超11%，$荣昌生物(09995)$、$复星医药(02196)$涨超7%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK1191","LU2399975544.HKD","BK1583","LU0880133367.SGD","LNGR","LU0315179316.USD","LU0417516738.SGD","LU1993786604.SGD","IBBQ","LU0540923850.HKD","LU0561508036.HKD","LU1794554557.SGD","BK1617","BK1521","LU0348827113.USD","LU1226288253.USD","LU2778985437.USD","LU1226287529.USD","LU0326950275.SGD","06978","02196","LU2476274720.SGD","LU2476274308.USD","IE00BZ08YR35.GBP","HK0000306685.HKD","09926","IE00B5MMRT66.SGD","159992","LU1152091168.USD","VXUS","IE00B543WZ88.USD","LU0348783233.USD","LU1152091754.HKD","LU1813983027.USD","LU0348825331.USD","BK1161","HK0000320223.HKD","LU0140636845.USD","LU0348735423.USD","SG9999004220.SGD","LU1951186391.HKD","HK0000306701.USD","IE0008368742.USD","BK1141","IE00BZ08YS42.EUR","09995","LU0501845795.SGD","LU1807302812.USD","KCAI","LU1969619763.USD","BK1574","LU0348784397.USD","BK1515","BK1593","IE0008369823.USD","02228","LU0348766576.USD","LU2039709279.SGD","IE00B031HY20.USD","HK0000165453.HKD","LU1008478684.HKD","LU0417516902.SGD","LU0072913022.USD","01548","KURE","LU0348767384.USD","MEDX","LU0314109678.HKD","01177","LU0417516571.SGD","LU1226287875.USD","LU1328277881.USD","01093","LU1226288170.HKD","BK1589","LU2488822045.USD","IE00BPRC5H50.USD","LU1720050803.USD","LU1960683339.HKD","LU0067412154.USD","LU2328871848.SGD","LU1961090484.USD","BK1576","LU1226287792.SGD","HK0000320264.USD","02157","LU0634319403.HKD","IE00BZ08YT58.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}